AP306
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AP306, covering 2024-12-02 to 2024-12-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Efficacy of AP306 At Fixed Doses in Patients with Hyperphosphatemia [Phase 2]